Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases.
about
Posttransplant lymphoproliferative disease after pediatric solid organ transplantationImmunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapyEstablishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease.Epstein-Barr virus-associated lymphomas.Impaired functionality of antiviral T cells in G-CSF mobilized stem cell donors: implications for the selection of CTL donor.Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.Ex vivo expansion of tumor-infiltrating lymphocytes from nasopharyngeal carcinoma patients for adoptive immunotherapyTreatment of lymphoma with adoptively transferred T cells.Immunotherapy for HIV-associated non-Hodgkin's lymphoma.Immunotherapy against EBV-lymphoma in recipients of HSCT.Immunotherapy for EBV-associated malignancies.T-cell therapies for Epstein-Barr virus-associated lymphomas.Burkitt lymphoma: the role of Epstein-Barr virus revisited.Cytomegalovirus-specific T-cell therapies: current status and future prospects.Adoptive cellular therapy with T cells specific for EBV-derived tumor antigens.EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.Cytolytic mechanisms and T-cell receptor Vbeta usage by ex vivo generated Epstein-Barr virus-specific cytotoxic T lymphocytes.Blood donor derived dendritic cells and cytotoxic T cells for specific fusion-gene adoptive immunotherapy.Selection of Epstein-Barr virus specific cytotoxic T lymphocytes can be performed with B lymphoblastoid cell lines created in serum-free media.A registry of HLA-typed donors for production of virus-specific CD4 and CD8 T lymphocytes for adoptive reconstitution of immune-compromised patients.Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry.Epstein-Barr virus, B cell lymphoproliferative disease, and SCID mice: modeling T cell immunotherapy in vivo.Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disorders.Adoptive cell therapy against EBV-related malignancies: a survey of clinical results
P2860
Q26866013-6230A7FB-07A8-40E8-ABCB-4322603FE9F7Q33289956-4AE3EE3D-8E16-4EB1-A644-568515FA6BDFQ33456742-F71CB464-605C-425E-8D1E-52150D43AD06Q34651670-70D411D1-C502-42E9-A5AA-22F4355C6CD5Q35063668-472E3674-368D-40C7-91D0-DEC3563C5182Q36556729-276F41A3-9B70-42E0-8C60-420D2C77DFB1Q37183682-889BE10F-8159-4CDA-80A9-E0D923BAE7BCQ37419728-391327CB-2501-4052-95B9-8BF4BEE451CEQ37567836-F4CBE733-EE94-45C3-B28C-3161DE71AFF0Q37810283-0DDAF020-F102-42B7-9996-6B8DFEBCB1C4Q37845178-228886B6-A3FE-476A-AA82-4E6FD88702D6Q37948940-0DC3E377-80E7-414F-8479-217887E86697Q38000577-14EA0B5B-4918-44CF-8653-38F98317FF81Q38365044-A458611A-98EE-4731-B104-61F2652E713CQ38570061-E6A240A6-7362-4B62-B093-90E35BF781FFQ38812004-B366F04E-7DC0-44B5-8A12-191346975518Q39825102-C7632BAB-9A7C-45AC-8C41-1AD920242E54Q40141710-5D906CFD-7DE4-439F-8B9C-718D7BD7B865Q40303777-CA6255E2-43C0-4958-8B55-76FAA92DF605Q42205114-1895E7AA-1CE4-4329-9AEC-9F2741F42C4BQ42271011-3EAF825E-882B-4A9A-9559-4663D8DED016Q45365121-4A2B61DD-AA84-4E3F-8A24-F1556A2D7F1BQ53560320-008EF9F5-115E-4C72-A7B7-F7D8C9B9C185Q57056125-DD2666D4-67A7-4565-8137-4429945AA49F
P2860
Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Establishment and characteriza ...... arr virus-associated diseases.
@ast
Establishment and characteriza ...... arr virus-associated diseases.
@en
type
label
Establishment and characteriza ...... arr virus-associated diseases.
@ast
Establishment and characteriza ...... arr virus-associated diseases.
@en
prefLabel
Establishment and characteriza ...... arr virus-associated diseases.
@ast
Establishment and characteriza ...... arr virus-associated diseases.
@en
P2093
P921
P1476
Establishment and characteriza ...... arr virus-associated diseases.
@en
P2093
Clare Taylor
David Kilpatrick
David M Burns
Dorothy H Crawford
Gwen M Wilkie
Marc Turner
Marie M Jones
Peter L Amlot
Tanzina Haque
P304
P356
10.1097/00002371-200407000-00007
P577
2004-07-01T00:00:00Z